For the quarter ending 2025-09-30, TDOC had $46,952K increase in cash & cash equivalents over the period. $96,984K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -49,507 | -125,672 |
| Goodwill impairments | 12,625 | 59,138 |
| Amortization of intangible assets | 85,757 | 172,968 |
| Depreciation of property and equipment | 2,612 | 7,902 |
| Amortization of right-of-use assets | 3,783 | 4,190 |
| Provision for allowances for doubtful accounts | -858 | 377 |
| Stock-based compensation | 16,996 | 47,507 |
| Deferred income taxes | 2,623 | -34,072 |
| Other, net | -1,223 | -2,049 |
| Accounts receivable | -16,161 | 8,497 |
| Prepaid expenses and other current assets | -15,108 | 16,434 |
| Inventory | 1,900 | -861 |
| Other assets | 1,225 | -7,616 |
| Accounts payable | -3,022 | 19,278 |
| Accrued expenses and other current liabilities | 2,902 | -5,149 |
| Accrued compensation | 4,750 | -9,545 |
| Deferred revenue | -3,693 | -6,084 |
| Operating lease liabilities | -5,079 | -5,170 |
| Other liabilities | 8 | -3,912 |
| Net cash provided by operating activities | 99,264 | 107,351 |
| Capital expenditures | 2,280 | 3,994 |
| Capitalized software development costs | 29,038 | 57,824 |
| Proceeds from the sale of investment | 0 | 740 |
| Acquisitions accounted for as business combinations, net of cash acquired | 16,602 | 65,302 |
| Asset acquisition resulting in net intangible assets | 0 | 29,569 |
| Payments for investments | 800 | 27,075 |
| Other, net | 0 | -60 |
| Net cash used in investing activities | -48,720 | -182,964 |
| Proceeds from the exercise of stock options | 0 | 81 |
| Proceeds from employee stock purchase plan | 517 | 1,384 |
| Repayment of convertible senior notes | 0 | 550,629 |
| Payment of credit facility issuance costs | 4,109 | - |
| Other, net | 0 | 0 |
| Net cash (used in) provided by financing activities | -3,592 | -549,164 |
| Net (decrease) increase in cash and cash equivalents | 46,952 | -624,777 |
| Effect of exchange rate changes on cash | 5,747 | - |
| Cash and cash equivalents at beginning of period | 1,298,327 | - |
| Cash and cash equivalents at end of period | 726,249 | - |
Teladoc Health, Inc. (TDOC)
Teladoc Health, Inc. (TDOC)